Filing Details

Accession Number:
0001019056-23-000276
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-16 16:14:09
Reporting Period:
2023-06-14
Accepted Time:
2023-06-16 16:14:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831097 Agilon Health Inc. AGL Services-Misc Health & Allied Services, Nec (8090) 371915147
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1855843 Benjamin Shaker C/O Agilon Health, Inc.
6210 E Hwy 290, Suite 450
Austin TX 78723
Chief Markets Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-14 1,851 $3.00 81,394 No 4 M Direct
Common Stock Disposition 2023-06-14 1,851 $17.93 79,543 No 4 S Direct
Common Stock Acquisiton 2023-06-14 15,799 $3.79 95,342 No 4 M Direct
Common Stock Disposition 2023-06-14 15,799 $18.60 79,543 No 4 S Direct
Common Stock Acquisiton 2023-06-14 1,100 $3.79 80,643 No 4 M Direct
Common Stock Disposition 2023-06-14 1,100 $19.17 79,543 No 4 S Direct
Common Stock Acquisiton 2023-06-15 18,750 $3.79 98,293 No 4 M Direct
Common Stock Disposition 2023-06-15 18,750 $18.73 79,543 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options (Right to buy) Disposition 2023-06-14 1,851 $0.00 1,851 $3.00
Common Stock Options (Right to buy) Disposition 2023-06-14 15,799 $0.00 15,799 $3.79
Common Stock Options (Right to buy) Disposition 2023-06-14 1,100 $0.00 1,100 $3.79
Common Stock Options (Right to buy) Disposition 2023-06-15 18,750 $0.00 18,750 $3.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2027-04-27 No 4 M Direct
434,201 2029-02-09 No 4 M Direct
433,101 2029-02-09 No 4 M Direct
414,351 2029-02-09 No 4 M Direct
Footnotes
  1. Includes restricted stock units.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.665 to $18.040, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.040 to $19.030, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.055 to $19.295, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.2600 to $19.100, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  7. These options were granted on April 27, 2017, and became fully vested as of September 14, 2021.
  8. These options were granted on February 9, 2019, and became fully vested as of February 9, 2023.